The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10913932 B1

PDF
Full Text
Expired
Date of Patent:
Feb. 09, 2021

Filed:

Jun. 03, 2016
Applicant:

Takara Bio Europe Ab, Gothenburg, SE;

Inventor:

Barbara Kuppers-Munther, Gothenburg, SE;

Assignee:

TAKARA BIO EUROPE AB, Gothenburg, SE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
C12N 5/067 (2013.01); C12N 2500/25 (2013.01); C12N 2500/30 (2013.01); C12N 2500/36 (2013.01); C12N 2500/38 (2013.01); C12N 2501/02 (2013.01); C12N 2501/06 (2013.01); C12N 2501/11 (2013.01); C12N 2501/12 (2013.01); C12N 2501/16 (2013.01); C12N 2501/237 (2013.01); C12N 2501/385 (2013.01); C12N 2501/39 (2013.01); C12N 2501/405 (2013.01); C12N 2501/415 (2013.01); C12N 2501/727 (2013.01); C12N 2501/999 (2013.01); C12N 2506/02 (2013.01); C12N 2506/45 (2013.01); C12N 2533/52 (2013.01); C12N 2533/54 (2013.01);
Abstract

The present invention relates to directed differentiation and maturation of mammalian hepatocytes, such as human hepatocytes. The hepatocyte obtained in accordance with the present invention show a phenotype which is more similar to that of primary hepatocytes than previously shown. In particular, the present invention relates to exposure of mammalian hepatocytes, such as human hepatocytes, to at least one maturation factor selected from the group consisting of Src kinase inhibitors, vitamin D including precursors, metabolites and analogs thereof, hypoxia inducing compounds, sphingosine and sphingosine derivatives, activators of peroxisome proliferator-activated receptors (PPARs), platelet-activating factor (PAF), PKC inhibitors, and combinations thereof.


Find Patent Forward Citations

Loading…